- Major Women’s Health Study Supports Hormone Replacement Therapy in Early Menopause
- Organic Walnuts Tied to Serious E. Coli Illnesses
- More Than Half of Cats on Farm Where Bird Flu Infected Cows Died After Drinking Milk
- Biden Administration Could Reclassify Marijuana as Less Risky Drug
- Americans of Pacific Island Ethnicity Have Up to Triple the Rate of Cancer Deaths
- How Anger Could Raise Your Heart Risks
- EPA Clamps Down on Deadly Toxin Found in Paint Strippers
- Popular Teens (Especially Girls) May Get Less Sleep
- Years Prior to Menopause Are Danger Zone for Depression
- School Entry Rules Boost Kids’ HPV Vaccination Rates
Gene Therapy Shows Promise for Inherited Eye Disease
A new study finds that gene therapy quickly improves eyesight for patients who’ve lost their vision from an inherited condition called Leber congenital amaurosis (LCA).
But the improvements aren’t permanent: Researchers said the gains began to diminish after one to three years.
“Gene therapy for LCA demonstrated we could improve vision in previously untreatable and incurable retinal conditions,” study leader Dr. Samuel Jacobson, of the University of Pennsylvania’s Scheie Eye Institute, said in a U.S. National Eye Institute release.
“Even though the current version of the therapy doesn’t appear to be the permanent treatment we were hoping for, the gain in knowledge … is an opportunity to improve the therapy so that the restored vision can be sustained for longer durations in patients,” Jacobson added.
Scientists started the research in 2007, looking at 15 people with the eye condition who received injections of a virus that carried certain genes.
“Within days of the injections, some patients reported increases in their ability to see dim lights they had never seen before,” Jacobson said. “It was remarkable for us to get this feedback that things were indeed changing positively.”
Dr. Paul Sieving, director of the National Eye Institute, said that six years of data shows that a gene-therapy approach is safe and successfully improves vision in people with LCA.
“As with any application of a novel therapy, it now needs to be fine-tuned. More research is needed to understand the underlying biology and how we can preserve or restore photoreceptors for a lifetime,” he said.
The study was published online May 3 in the New England Journal of Medicine.
More information
For more about Leber congenital amaurosis, try the U.S. National Library of Medicine.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.